Alibaba Health Information Technology Limited
0241
Rangering i aksjer
#3018
Alibaba Health Information Technology Limited, an investment holding company,... Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, healthcare food, adult and family planning products, and various other health-related products. It also provides medical and healthcare services, including medical checkups, medical consultation, appointment-booking, vaccination, dental and mental care, optometry, and nursing services, as well as traditional chinese medicines. The company provides products and services to business-to-customer and business-to-business customers through offline pharmacy outlets, as well as online stores, such as Tmall, Taobao, Alipay, Ele.me, AMap, DingTalk, Freshippo, and Quark. In addition, it engages in the digital tracking business; asset management; network hospital, software technical services, healthcare related internet information and technical services and research; operation of internet hospitals, as well as Alibaba Health, flagship platform of Alibaba Group for integrated online and offline medical and healthcare resources, providing one-stop healthcare solutions. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. Alibaba Health Information Technology Limited was incorporated in 1998 and is based in Causeway Bay, Hong Kong.
Aksjekurs
$0.37546349
Markedsverdi
$6.07B
Endring (1 dag)
-3.77%
Endring (1 år)
-52.40%
Land
HK
Handel Alibaba Health Information Technology Limited (0241)
Kategori
Healthcare
P/E-forhold for Alibaba Health Information Technology Limited (0241)
P/E-forhold per October 2026 TTM: 20.75
Ifølge Alibaba Health Information Technology Limited sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/E-forhold (TTM) 20.75. Ved slutten av 2024 hadde selskapet en P/E på 45.22.
P/E-forholdshistorikk for Alibaba Health Information Technology Limited fra 2004 til 2026
P/E-forhold ved slutten av hvert år
| År | P/E-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 20.75 | -57.88% |
| 2025 | 49.27 | 8.94% |
| 2024 | 45.22 | -63.88% |
| 2023 | 125.22 | -160.00% |
| 2022 | -208.70 | -129.63% |
| 2021 | 704.30 | -103.28% |
| 2020 | -21.44K | 2,011.22% |
| 2019 | -1.02K | 279.53% |
| 2018 | -267.62 | 119.20% |
| 2017 | -122.09 | -27.23% |
| 2016 | -167.77 | -67.80% |
| 2015 | -521.04 | -84.11% |
| 2014 | -3.28K | 8,214.77% |
| 2013 | -39.45 | -82.87% |
| 2012 | -230.32 | 46.15% |
| 2011 | -157.59 | 25.02% |
| 2010 | -126.05 | 3,538.25% |
| 2009 | -3.46 | -85.86% |
| 2008 | -24.49 | -46.94% |
| 2007 | -46.17 | -107.88% |
| 2006 | 586.00 | 28.82% |
| 2005 | 454.91 | -128.53% |
| 2004 | -1.59K | 0.00% |
P/E-forhold for lignende selskaper eller konkurrenter
| Selskap | P/E-forhold | Forskjell i P/E-forhold | Land |
|---|---|---|---|
| 19.68 | -5.20% |
US
|
|
| 64.40 | 210.31% |
AU
|
|
| 44.30 | 113.46% |
US
|
|
| -47.78 | -330.20% |
US
|
|
| -123.90 | -696.99% |
US
|
Hvordan lese en P/E-ratio?
Pris/inntjening-forholdet (P/E) måler forholdet mellom aksjekursen og inntjening per aksje.
En lav men positiv P/E indikerer høy inntjening sammenlignet med nåværende verdsettelse, og kan tyde på at selskapet er undervurdert. En høy negativ (nær 0) P/E indikerer store tap.
Selskaper med P/E over 30 eller negativ betraktes vanligvis som "vekstaksjer", hvor investorer forventer vekst eller fremtidig lønnsomhet.
Selskaper med en positiv P/E under 10 anses vanligvis som "verdiaksjer", det vil si at selskapet allerede er lønnsomt, men har begrenset vekstpotensial.